Allelic forms (Tamsl- calves were challenged with a T. annulata stabilate generated from blood of an infected animal with 30% piroplasm parasitaemia. All calves vaccinated with ISCOMs proved to be protected from T. annulata infection and had generated antibodies against both re-(Tamsl-1 and Tamsl-2) at the time of challenge. In two of these animals the antibody had a surface binding profile by IFAT. Two of three calves immunized with naked DNA also proved to be protected, but none of the animals had generated any detectable antibodies against the recombinants. Salmonella-based delivery of the recombinants did not induce any protection; two of six animals died of theileriosis and there was no difference between subcutaneous or oral administration These preliminary results show that re-(Tamsl-1 andlor Tams1 -2) may elicit protective immune responses in cattle, depending on the antigen delivery system. 0 1997 Elsevier Science Ltd.
The protozoan parasite Theiletia annulata infects cattle and domestic buffalo (Bubalus b&a/is) across an area stretching from southern Europe and northern Africa, through the Middle East and southern Russia into India and southern China'. T anndata is transmitted by ticks of the genus Hyafomma and more than 250 million domestic cattle have been estimated to be at risk from tropical theileriosis'. Infection in the bovine is initiated by inoculation of sporozoites from infected ticks during feeding. These invade mononuclear leucocytes (thought primarily to be monocytes and B-cells expressing MHC class II antigens".4), where they develop into multinucleated macroschizonts and induce host cells to divide in synchrony with the macroschizont. These parasites develop further from microschizonts into free merozoites, which upon release from the leucocyte invade erythrocytes to develop into piroplasms.
Tropical theileriosis is currently controlled by chemotherapy, tick control using acaricides and vaccination using attenuated macroschizont-infected lymphoid cell lines. Although these live vaccines are being used with success in endemic areas'-"', their lnducfion of protective immunity to Theileria annulata: C. d 'O/iveira et al. application has a number of drawbacks. The vaccine lines need to be evaluated for their ability to protect against challenge, require prolonged in vitro passage to become attenuated and it is not clear whether attenuated cells can revert to virulence in vivo. Such prolonged passage can also lead to lines losing their ability to immunize recipient animals as a result of the inability of the macroschizonts to transfer into the cells of the vaccinated animal. Furthermore, although cattle are protected by the attenuated cell line vaccine, it does not prevent the development of the erythrocytic stages when animals are challenged". In addition, once thawed the vaccine has a short half life and there is the possibility of transferring other pathogens by the use of such live vaccines. Many of these limitations could be overcome by the production of immunogenic antigens by re-DNA techniques and development of a subunit vaccine against tropical theileriosis.
One antigen (SPAG-1) has been identified on the surface of the sporozoite by a mAb which blocks sporozoitc penetration of bovine peripheral blood mononuclear cells in vitro". A C-terminal fragment (SRI) of SPAG-I has been expressed as a fusion protein in the el loop of hepatitis B core antigen (HBcAg) and used to immunize calves in a small scale vaccination trial. High antibody titres were generated in all four animals immunized with HBcAg-SRI and IFAT confirmed that there was recognition of the sporozoite surface. Clinical symptoms were delayed on sporozoite challenge; however, all the animals eventually developed disease".
The merozoite stage is, like the sporozoite, invasive and also a potential target for a protective immune response. Recently, allelic forms of Tams1 (TurnsIand Tumsl-2) which encode the 30 kDa and 32 kDa major merozoite surface antigens of 7: annufutu, respectively, have been expressed in a Salmonella typhimurium aroA vaccine strain and Escherichia coli". Immunostimulating complexes (ISCOMs) were prepared from both recombinants purified from E. coli. As a third route to deliver re-(Tamsl-1 and Tamsl-2) to the bovine host, both genes were subcloned into an eukaryotic expression vector and used as a DNA vaccine. In this paper we evaluate the potential of these three systems as a component of a multistage subunit vaccine against tropical theileriosis in cattle.
MATERIALS AND METHODS

Bacterial strains and culture
Escherichia coli MlS[pREP4] '" and Salmonella typhimurium SL3261" producing re-(Tamsl-1 or Tams1 -2) were grown as described previouslyi4. S. typhimurium SL3261 [pSTamsl-l] [pIPS]
and SL3261 ]pIP5] used for animal experiments were washed in PBS and each was resuspended at 1 x IO9 ml -' and 2 x IO"' ml ' for subcutaneous and oral administration, respectively. The bacteria were checked for the correct aro, his, ApR and KmR phenotypes by selection on appropriate minima1 plates" with or without 10 pg ml-' para-aminobenzoic acid; 10 1.18 ml-' 2,3_dihydroxyben-zoic acid, 40 pg,rnl~ phenylalanine, 40 pg ml ' tyrosine, 40 /Lg ml histidine, 40 pg ml -' tryptophan, and by culture on LB plates supplemented with 100 pg ml ' ampicillin (Ap) and 25 pg ml-' kanamycin (Km). To distinguish S. typhimurium from E. coli, growth was tested on brilliant green agar (BGA) plates. Smooth LPS phenotype was determined by examining LPS profiles on silver-stained gels'". Briefly, whole cell lysates were boiled for 10 min, incubated with 125 ;lg proteinase K at 60°C for 1 h and subsequently examined by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) followed by silver staining. S. typhimurium-Smooth and -Rough (ATCC 14028) kindly provided by Dr J.G. Kusters, and E. coli were used as controls. Tamsl-2) respectively, were performed as described previously'4. For the preparation of ISCOMs, recombinants were mixed separately with cholesterol, phosphatidylcholine (Sigma Chemical Co., St. Louis, MO, USA) and Quil A (Spikoside, Iscotec, Lulea, Sweden) at a ratio of 1:1:5 (w/w/w). After ultrasonic treatment for 10min the mixture was incubated for 1 h at room temperature. Subsequently, the mixture was extensively dialysed against 10 mM Tris-HCI (pH 7.4) 0.3 M NaCl, layered over a linear (lo-60%) sucrose gradient and centrifuged for 18 h at 25 K (Beckmann SW28 rotor). Fractions containing peak levels of the recombinants (coinciding with the presence of ISCOM-like structures, as judged by negative contrast electron microscopy) were pooled. For SDS-PAGE and subsequent Western blotting, ISCOMs were pelleted by ultracentrifugation for 4 h at 40 K and resuspended in PBS (l/l 0 of the initial volume).
Cloning of Tamsl-l and Tamsl-2 in pSLRSV.Nul Primers for PCR were chosen which were complementary to conserved sequences flanking Tamsl-l and Tamsl-2. Primer 1: 5'-GGAATTAGATCTfiTTGT-CCAGGACCACC-3' and primer 2: 5'-AATICCA-GATCTGGGTT-MGGAAGTAAAGG-3'. BglII restriction sites (presented in bold) were incorporated to facilitate subsequent cloning. The positions of the start and stop codons are underlined in primer 1 and primer 2, respectively. PCR was performed in a final reaction volume of 100 ~1 containing 50 mM KC], 10 mM Tris-HC1 (pH 8.3) 0.1% Triton X-100, 1.5 mM MgCl?, 200 !cM (each) deoxynucleoside triphosphate, 80 pmol of each primer, 2.5 U Tuq polymerase (Promega, Madison, WI, USA) and 10 ng of plasmid DNA containing Tamsl-l or Tams]-2. Reactions were performed in an automatic DNA thermal cycler (Perkin-Elmer, Foster City, CA, USA) for 30 cycles comprising denaturation at 94°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 1 min. The resulting 851-bp fragments were separated by electrophoresis on a 1.2% low-melting point agarose gel and isolated using QiaexII (Qiagen, Chatsworth, CA, USA). These fragments containing the complete coding sequence of Tumsl-l and Tamsl-2, were ligated into expression vector pSLRSV.Nul, digested with BglII and treated with Calf-Intestinal-Phosphatase". Plasmid pSLRSV.Nul/BglII-version was kindly provided by Prof. L. Babiuk and modified by Dr J.
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The resulting plasmids pBglII30 and pBglII32 contained the 30 kDa and 32 kDa merozoite surface antigen coding sequences, respectively, both under control of the Rous Sarcoma Virus-Long Terminal Repeat promoter and the SV-40 polyadenylation signal. The plasmid backbone was derived from pSL301TM (Invitrogen, San Diego, CA, USA). Both plasmids were purified from E. coli DHSa using Qiagen columns (Qiagen) and verified by nucleotide sequence analysis".
Immunizations
neck.
Experimental calves (Bos ~CIUTCIS), 5-6 months of age and kept in experimental tick-proof pens were used in the experiments.
Fifteen calves were allocated randomly into five groups of three animals each and immunized according to the schedule summarized in Table I . Each immunization consisted of two preparations: one contained re-(Tamsl-l),
given on the righthand side in the neck of the animal, and the other contained re-(Tamsl-2), given on the left-hand side in the
Group I: 1 ml ISCOM vaccine given intramuscularly, containing 20 /lg re-(Tamsl-l or Tams1 -2); Group II: 1 ml DNA vaccine given intramuscularly, containing 500 pg of pBglI130 or pBglI132 dissolved in TE [lo mM Tris-HCI (pH 8), 1 mM EDTA]; Group III: 1 ml Salmonella vaccine given subcutaneously, containing 1x10" S.
Group IV: 5 ml Salmonella vaccine given orally,
Group V: three unimmunized control calves were infected with T. annulclta only.
Rectal temperatures were taken daily and blood was collected weekly for sera analysis. Additional blood samples were collected three times weekly in citrate buffer for the preparation of blood smears and determination of packed cell volume (PCV). The remainder of the blood sample was stored at -20°C for PCR analysis. 7: annuluta piroplasms were counted in Giemsa-stained blood smears. When very scanty, their presence was confirmed by PCR and subsequently Southern hybridization using Tamsl-I cDNA as a probe, as described previously'4. Blood samples for PCR were collected from Groups I and II prior to challenge and in weeks 2, 3, 4, 8 and 12 postchallenge. Saponin lysis mix (0.22% NaCl, 0.015% saponin, 1 mM EDTA) was added to 50 /II of blood and the mixture was centrifuged for 1 min. Pellets were washed three times with saponin lysis mix, resuspended in 100 ![I PCR buffer (50 mM KCI, 10 mM Tris-HCI (pH 8) 0.5% Tween 20, 100 /lg proteinase K mll ) and incubated at 56°C for 1 h. After 10 min at 95°C 5 it1 were used for PCR, performed as described above.
Challenge
Calf 184 was experimentally infected with 7: annulatu (Ankara, Turkey)-" administered as a ground-up tick supernate, kindly provided by Prof. C.G.D. Brown. When the parasitaemia (piroplasms) reached 30%, blood was frozen with 10% DMSO in 2 ml aliquots at -80°C representing approximately 6 x 10' piroplasms per aliquot, plus an unknown number of macroschizont-infected leucocytes.
Control and immunized animals were challenged with this stabilate administered subcutaneously (1 ml) and intravenously (1 ml) in the neck of the animal (Tuhle I).
Western blotting
Column-purified re-(Tamsl-1 and Tamsl-2) and proteinase K-digested whole cell lysates of S. typhimurium SL3261
were separated by 0.1% SDS-12% PAGE". Purified S. typhimurium LPS (Sigma) was used as a control. Subsequently, Western blot analysis was performed using preimmune, prechallenge and postchallenge sera from immunized calves at a 1:lOO dilution and, as a control, rabbit anti-LPS serum, kindly provided by Edwin J. Tijhaar. Pelleted ISCOMs were separated and the Western blot analysed as described above, using immune serum from calf 184. Ab-Ag complexes were visualized using ECL immunodetection (Amersham, Buckinghamshire, UK).
Indirect immunofluorescent antibody assay
7: armulata (Ankara, Turkey)ls piroplasm infected erythrocytes were prepared by centrifugation of blood at SOOg for 10 min. Pelleted cells were washed twice in PBS, resuspended to a density of approximately 3 x 10' ml-' and fixed in acetone at -20°C for 20 min. The indirect antibody test was carried out essentially as described by Minami et ~1.'~. Briefly, sera isolated at the time of challenge from ISCOM immunized animals (Group I) and control calf 476 (Group V) and at weeks 2, 3 and 9 postchallenge were assayed by incubating 20 111 of a 1:50 dilution (in PBSRO% horse serum) on each well at room temperature for 30 min, followed by washing three times with PBS. Fluorescein-conjugated rabbit anti-bovine IgG (Sigma) was added to each well and incubated for a further 30 min at room tempera- Table 1 Vaccination schedule for four groups of three calves each immunized with re-(Tamsl-1 and Tamsl-2) either prepared as ISCOMs, encoded on plasmid pBglll30 and pBglll32, respectively, or produced in S. typhirnurium vaccine strain SL3261 ture. After washing as above, slides were stained with 0.1% Evans blue, mounted with 50% glycerol in PBS and examined by microscopy under UV illumination at x 500 magnitication".
RESULTS
ISCOM immunized calves
The characteristic cage-like structure of the ISCOMs was confirmed by electron microscopy after negative staining (data not shown). After performing SDS-PAGE of the pelleted ISCOMs, Western blot analysis using 7: annulata immune calf serum revealed bands at approximately 32 kDa and 33 kDa ( Figure  I(A) , lanes I and 2) confirming the presence of purified re-(Tamsl-1) and re-(Tamsl-2) respectively ( Figure Z(A), lanes 3 and 4) .
Group I calves were immunized twice with ISCOMs intramuscularly, with an interval of 4 weeks (Table I ) and proved to be protected against 7: anndctu challenge (Tahlr 2). Western blot analysis revealed that all three animals had generated antibodies against
B
Figure 1 (A) Western blot analysis of re-(Tamsl-1 and Tamsl-2) ISCOMs (lanes 1 and 2, respectively) using T. annul&a immune serum, and Coomassie brilliant blue-stained re-Tamsl-1 and re-Tamsl-2 proteins run in parallel (lanes 3 and 4, respectively). (6) SDS-PAGE of S. typhimurium LPS stained with silver (lanes 1 and 2) and Western blot analysed using rabbit anti-LPS serum (lanes 3 and 4). Lanes: 1, S. typhimurhm SL3261; 3, purified S. Figure 2(A), lanes 1, 2, 5, 6, 9 and IO]. Although there were equal amounts of recombinant proteins loaded onto the gel [ Figure I (A), lanes 3 and 41, the sera preferentially detected re-(Tamsl-2) [ Figure 2(A) , lanes 2, 6 and lo], indicating that it was more immunogenic than the ISCOMs prepared from re-(Tams]-1) [ Figure  2 (A), lanes 1, 5 and 91. Specific antibody levels were maintained in the sera of all three animals at least until week 23 postchallenge when the experiment was terminated [ Figure 2(A), lanes 3, 4. 7. 8, 11 and 121, whereas the levels in control calf 476 (Group V) were almost non-detectable [ Figure 2(A) , lanes 15 and 161. Furthermore, sera taken at the time of challenge from calves 473 and 474 reacted with piroplasm antigen in IFAT, whereas serum from calf 475 showed a weak recognition (Figure 3) . Sera taken from the three immunized and one control animal at week 9 postchallenge recognized the piroplasms and prcimmune sera did not react with tither the recombinants or piroplasms (data not shown).
typhimufium LPS (Sigma)
The protected animals (Nos. 473, 474 and 475) were confirmed to be 7: annuhta carriers by PCR (Figure 4 and Southern hybridization 
Naked DNA immunized calves
Group II was immunized three times intramuscularly at 4-week intervals using 500 /lg pBglII30 and 500 /lg pBglI132 in each immunization (Ehle I). SDS-PAGE and Western blot analysis with sera collected just before every boost or challenge did not reveal any detectable antibodies against the recombinants. Sera used at a 1:lO dilution instead of 1 :lOO was also negative (data not shown). However, calves 520 and 521 were protected, whereas calf 519 was not ( 
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Groups III and IV were immunized twice subcutaneously and orally, respectively, with Salmonella producing re-(Tamsl-1 and Tamsl-2) (Table I ). All animals developed fever accompanied by piroplasm parasitaemia. Calves 9263 (Group III) and 1045 (Group IV) died of acute theileriosis. The other two animals from Group III developed a parasitaemia of 8% whereas the two remaining animals from Group IV exhibited a maximum parasitaemia of 3%. Western blot analysis showed that all immunized animals had been infected with Salmonella at the time of challenge (Figures 2(B) and 2(C) extent against re-Tamsl-2 at the time of challenge [ Figure 2(B), lanes 1, 2, 9 and lo]. Preimmune sera taken from the same animals did not react with either recombinant antigen or LPS (data not shown). As a control, anti-Salmonella LPS serum raised in rabbit reacted with Saimon&-LPS [ Figure I (B), lanes 3 and
41.
DISCUSSION
In the present paper we have shown the ability of re-(Tamsl-1 and/or Tamsl-2) to induce protective immunity in cattle against tropical theileriosis, using ISCOMs and naked DNA to deliver these antigens, whereas all three unimmunized control animals developed disease. Salmonella-based delivery did not induce any protection; in contrast, two of six animals died of tropical theileriosis.
ISCOM immunized calves
At the time of challenge, all three ISCOM immunized calves had generated antibodies which recognized the piroplasm by IFAT. The pattern of staining was identical to that detected by monoclonal 5E1, which has been shown to bind to the surface of the merozoite", suggesting that antibody generated against the ISCOMs results against the merozoite surface. Therefore, protection may have been due to high amounts of circulating antibodies to re-(Tamsl-1 and Tamsl-2) which bind to the merozoite surface and prevent invasion of erythrocytes or opsonize the parasite for clearance in the spleen by macrophages. Serum from calf 475 showed a weak reaction in IFAT compared with the other two calves, which might be the reason why the animal developed a higher piroplasm parasitaemia (1%). To investigate the possibility of a Th-cell mediated immunity, a lymphocytestimulation assay will be used in further studies to characterize the phenotype of Th cells elicited by inoculation of re-(Tamsl-1 and/or Tamsl-2).
Since ISCOMs were described by Morein et al.'", numerous studies have demonstrated their potential as a vaccine with built-in adjuvant properties. Bacterial, parasitic, viral and other proteins and peptides have been incorporated into ISCOMs to enhance the immune response in various ways, including activation of helper"" and cytotoxic"' T cells and eneration of potent long-lasting antibody B responses. . Protection against lethal Toxoplasma gondii33, Trypanosoma cruzi34 and Eimeria falcifotmis" infections has been induced in mice by immunization with ISCOMs containing one or several isolated parasite antigens.
Naked DNA immunized calves
Two of three naked DNA immunized calves were protected, although one had fever for 1 day accompanied by a maximum piropiasm parasitaemia of 1%. There were no detectable antibodies generated against the recombinants, which suggests that protective immunity is dependent on T cells. Sedegah et a1. 36 have shown 68% protection in mice against PZasmodium yoefii infection using plasmid DNA encoding the IT yoefii circumsporozoite protein, and that protection was dependent on CD8' T cells.
Intradermal instead of intramuscular administration may improve the results3'. Skin-associated lymphoid tissues contain specialized cells that enhance immune responses, e.g. the dendritic cell and the macrophages of the dermis can also take up antigen and initiate immune responses. Therefore, the in vivo transfection of epidermal or dermal cells by DNA would be expected to provide a more efficient route for DNA immunization. A further improvement may be gene gun-based DNA immunization using a hand-held gene delivery instrument that requires > 5000-fold less DNA to induce similar responses via intramuscular or intradermal inoculation3'.
Recombinant SufmoneIlu immunized calves
None of the recombinant Salmonella immunized calves were protected, and two of the six animals died of tropical theileriosis. Only calves 3033 and 9263 had generated antibodies against re-(Tamsl-1 or Tamsl-2) at a relatively low level at the time of challenge and, in contrast to the ISCOM antisera, these were biased towards the re-Tamsl-1 protein. Moreover, calf 9263 died of tropical theileriosis. This observation suggests that the recombinants were not produced at sufficient levels or in the appropriate form to induce adequate humoral and/or cell-mediated responses, possibly due to plasmid instability or toxicity of the recombinants in vivo. We recently reported that pSTamsl-1 or pSTamsl-2 and pIP5 can be maintained for at least 48 h in S. typhimurium SL3261 in vitro14. Stabilization of antigen production could be further attained b Y insertion of the gene into the bacterial chromosome". Also, Sadoff et af.39 have shown that the gene encoding the circumsporozoite (CS) antigen of I? bevghei when expressed in S. typhimurium can induce an antigenspecific cell-mediated immune response in mice and provided protection against sporozoite challenge in the absence of measurable antibody to CS protein.
Control calves
Group V animals received infected blood only and exhibited a very quick increase in piroplasm parasitaemia (from 5 to 20% in 24 h). Furthermore, on Giemsa-stained blood smears no Maltese crosses were detected which are typical for division of piroplasms within erythrocytes. Instead, multiple piroplasm infections were seen within individual erythrocytes, indicating the presence of macroschizont-infected leucocytes in the blood stabilate which differentiate to produce merozoites. This could be directly from infected cells within the stabilate or, more probably, following transfer of the schizont to the host cell of the immunized animal. Indeed, macroschizont-infected leucocytes could be detected in the spleen and liver of both animals that died. As it is known that Tamsl-I is produced by macroschizonts'" (at a low level) before differentiation to merozoites occurs, it is conceivable that peptides from these molecules are presented on the infected leucocyte together with MHC-I and recognized by cytotoxic T cells. Alternatively, the production of INF-y by Thl cells may activate macrophages and prevent the establishment of the macroschizont within leucocytes, as previously shown in vitro by Preston et a1. 40 and Visser et al."'. As we did not obtain data on the T cell response in immunized animals, the mechanism by which protection occurs is unclear at the present time. Further immunization trials are being conducted using ISCOMs with re-(Tamsl-1 and Tamsl-2) proteins combined with re-SPAG, and naked DNA encoding these proteins. Ultimately, it is likely that a subunit recombinant vaccine consisting of engineered antigens from sporozoites, schizonts as well as from merozoites/piroplasms will be necessary to induce protection against 7: annufutu infection, initiated through the bite of an infected tick. 
